Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |